Eddie Reed

1000 total citations
25 papers, 791 citations indexed

About

Eddie Reed is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Eddie Reed has authored 25 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Eddie Reed's work include Cancer Treatment and Pharmacology (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and DNA Repair Mechanisms (5 papers). Eddie Reed is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and DNA Repair Mechanisms (5 papers). Eddie Reed collaborates with scholars based in United States, Ukraine and Malaysia. Eddie Reed's co-authors include Meenakshi Dabholkar, Benjamín C. Bostick, Charles E. Egwuagu, Vilhelm A. Bohr, C. Weber, Elise C. Kohn, Gisele Sarosy, Charles J. Link, Justine Vionnet and William D. Figg and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Eddie Reed

24 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eddie Reed United States 13 326 323 248 124 115 25 791
B D Evans New Zealand 11 362 1.1× 217 0.7× 113 0.5× 115 0.9× 41 0.4× 24 728
NH Mulder Netherlands 18 644 2.0× 510 1.6× 142 0.6× 130 1.0× 59 0.5× 58 1.1k
Michael A. Levesque Canada 19 407 1.2× 405 1.3× 116 0.5× 336 2.7× 120 1.0× 32 1.2k
ES Newlands United Kingdom 16 258 0.8× 336 1.0× 96 0.4× 120 1.0× 82 0.7× 38 1.0k
G. Lelli Italy 13 368 1.1× 167 0.5× 78 0.3× 223 1.8× 89 0.8× 46 876
Suzanne Berlin United States 15 408 1.3× 333 1.0× 223 0.9× 204 1.6× 451 3.9× 37 1.3k
Von Hoff United States 16 540 1.7× 295 0.9× 170 0.7× 171 1.4× 28 0.2× 39 1.1k
S. J. Harland United Kingdom 18 390 1.2× 398 1.2× 105 0.4× 219 1.8× 172 1.5× 32 1.1k
E. A. Eisenhauer Canada 16 404 1.2× 357 1.1× 142 0.6× 251 2.0× 504 4.4× 31 1.2k
Paula Calvert Ireland 12 308 0.9× 195 0.6× 110 0.4× 194 1.6× 63 0.5× 41 657

Countries citing papers authored by Eddie Reed

Since Specialization
Citations

This map shows the geographic impact of Eddie Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie Reed more than expected).

Fields of papers citing papers by Eddie Reed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddie Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie Reed. The network helps show where Eddie Reed may publish in the future.

Co-authorship network of co-authors of Eddie Reed

This figure shows the co-authorship network connecting the top 25 collaborators of Eddie Reed. A scholar is included among the top collaborators of Eddie Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddie Reed. Eddie Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reed, Eddie, et al.. (2010). Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age. Cancer. 71(S2). 650–655. 2 indexed citations
2.
Reed, Eddie, Kenneth H. Cowan, PI Warkentin, et al.. (2009). Autologous dendritic cell vaccine directed at wild type p53 in patients with high-risk breast cancer treated with adjuvant chemotherapy.. Cancer Research. 69(2_Supplement). 2152–2152. 2 indexed citations
3.
Yu, Jing, et al.. (2000). Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues. Cancer Letters. 151(2). 127–132. 9 indexed citations
4.
Li, Qingdi, Benjamín C. Bostick, & Eddie Reed. (1998). Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line.. PubMed. 18(4A). 2283–7. 12 indexed citations
5.
Figg, William D., Glenn S. Kroog, Paul H. Duray, et al.. (1997). Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma. Cancer. 79(10). 1964–1968. 9 indexed citations
6.
Dixon, Shannon C., et al.. (1997). In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3. Cancer Letters. 113(1-2). 111–116. 13 indexed citations
7.
Reed, Eddie, Gisele Sarosy, Elise C. Kohn, et al.. (1996). A Phase I Study of Paclitaxel and Cyclophosphamide in Recurrent Adenocarcinoma of the Ovary. Gynecologic Oncology. 61(3). 349–353. 4 indexed citations
8.
Link, Charles J., Eddie Reed, Gisele Sarosy, & Elise C. Kohn. (1996). Borderline ovarian tumors. The American Journal of Medicine. 101(2). 217–225. 63 indexed citations
9.
Dabholkar, Meenakshi, Mitchel S. Berger, Justine Vionnet, et al.. (1995). Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.. PubMed. 55(6). 1261–6. 38 indexed citations
10.
Link, Charles J., Gisele Sarosy, Elise C. Kohn, et al.. (1995). Cutaneous manifestations of taxol® therapy. Investigational New Drugs. 13(3). 261–263. 12 indexed citations
11.
Figg, William D., Alain Thibault, Michael R. Cooper, et al.. (1995). A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer. Cancer. 75(8). 2159–2164. 40 indexed citations
12.
Motzer, Robert J., Eddie Reed, Deliang Tang, et al.. (1994). Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay. Cancer. 73(11). 2843–2852. 32 indexed citations
13.
Dabholkar, Meenakshi, et al.. (1993). PLATINUM-DNA ADDUCT IN HEAD AND NECK-CANCER PATIENTS RECEIVING CISPLATIN AND CARBOPLATIN CHEMOTHERAPY. International Journal of Oncology. 3(2). 331–5. 13 indexed citations
14.
Bicher, Annette, Elise C. Kohn, Gisele Sarosy, et al.. (1993). The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor. Anti-Cancer Drugs. 4(2). 141–148. 8 indexed citations
15.
Reed, Eddie, et al.. (1993). Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin. Gynecologic Oncology. 50(2). 147–158. 202 indexed citations
16.
Sarosy, Gisele, et al.. (1993). Incapacitating Autonomic Neuropathy Precipitated by Taxol. Gynecologic Oncology. 51(2). 277–280. 30 indexed citations
17.
Pai, Lee H., Sandra M. Swain, David Venzon, et al.. (1992). Therapy off patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin. Anti-Cancer Drugs. 3(5). 463–470. 5 indexed citations
18.
Dabholkar, Meenakshi & Eddie Reed. (1992). Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines. Cancer Letters. 63(2). 143–150. 2 indexed citations
19.
Dabholkar, Meenakshi, Benjamín C. Bostick, C. Weber, et al.. (1992). ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer Patients. JNCI Journal of the National Cancer Institute. 84(19). 1512–1517. 254 indexed citations
20.
Reed, Eddie, J Jacob, R F Ozols, Robert C. Young, & Carmen J. Allegra. (1992). 5-fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma. Gynecologic Oncology. 46(3). 326–329. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B D Evans Breakdown of academic impact, for papers by NH Mulder Breakdown of academic impact, for papers by Michael A. Levesque Breakdown of academic impact, for papers by ES Newlands Breakdown of academic impact, for papers by G. Lelli Breakdown of academic impact, for papers by Suzanne Berlin Breakdown of academic impact, for papers by Von Hoff Breakdown of academic impact, for papers by S. J. Harland Breakdown of academic impact, for papers by E. A. Eisenhauer Breakdown of academic impact, for papers by Paula Calvert
Rankless by CCL
2026